While an increasing number of options exist for effectively treating patients with HIV infection, many clinicians find it challenging to keep abreast of important developments in HIV therapeutics. To address this problem, this CME dinner program series will use case studies to highlight and discuss the relative merits and clinical significance of new findings in HIV medicine presented at the 20th International AIDS Conference (AIDS 2014). Because the focus of the dinner programs will be on case studies, participants will need to be familiar with data from AIDS 2014 that may be applied and discussed. Therefore, prior to attending a dinner program, participants will view an Internet presentation that summarizes and discusses the key data presented at AIDS 2014. As a result of this blended learning approach, participants will not only gain an increased understanding of key data presented at AIDS 2014, they will also be prepared to use these data in the clinic to address HIV-positive patients' health needs and provide the optimal care available, which will help to improve virologic suppression and antiretroviral adherence, increase the delivery of individualized care, reduce resistance and treatment failure, and improve patient outcomes and quality of life.
This program is produced by the Postgraduate Institute for Medicine and ViralEd, Inc.. It is not a session created by or presented at AIDS 2014 and it is not sanctioned by AIDS 2014.
This activity has been designed to meet the educational needs of physicians, physician assistants, advanced practice nurses and other health care professionals involved in the care of patients with HIV infection.
After completing this activity, the participant should be better able to:
Employ the current treatment paradigms for HIV/AIDS, including the studies and data presented at AIDS 2014 to improve patient care
Thursday, July 31, 2014 Durham, NC |
Tuesday, August 5, 2014 Detroit, MI |
Wednesday, August 13, 2014 San Diego, CA |
Wednesday, August 13, 2014 Kansas City, MO |
Tuesday, August 19, 2014 Baltimore, MD |
Wednesday, August 20, 2014 Cleveland, OH |
Thursday, August 21, 2014 Phoenix, AZ |
Calvin J. Cohen, MD, MS
Research Director
CRI New England
Clinical Instructor
Harvard Medical School
Boston, Massachusetts
Joseph Eron, MD
|
Ian Frank, MD
|
Trevor Hawkins, MD Associate Clinical Professor Department of Family Practice University of New Mexico Chief Medical Officer, Southwest C.A.R.E. Santa Fe, New Mexico |
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and ViralEd, Inc.. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The Postgraduate Institute for Medicine designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credit(s)TM.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
As of August 1, 2013, pharmaceutical companies are required by the open payments act (AKA Sunshine Act) to account for certain transfers of value provided to physicians. The federal guidance for the Sunshine Act provides exceptions for CME expenses that meet certain criteria. We believe the program to which you are invited meets these exceptions, and therefore we will not be collecting, nor reporting, any information gathered from this program. If federal guidance is further clarified in the future, we will then provide that information to the supporting pharmaceutical companies to the best of our ability.
The Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.
Supported by an educational grant from Gilead Sciences Medical Affairs.
This coverage is not sanctioned by the conference organizers and is not an official part of the conference proceedings.